Aspen Pharmacare 

$8.08
23
+$0.45+5.9% Wednesday 18:57

Statistics

Day High
7.87
Day Low
7.87
52W High
8.86
52W Low
5.24
Volume
5
Avg. Volume
470
Mkt Cap
3.61B
P/E Ratio
-
Dividend Yield
1.49%
Dividend
0.12

Upcoming

Dividends

1.49%Dividend Yield
Oct 25
$0.12
Oct 24
$0.21
Oct 23
$0.18
Oct 22
$0.18
Oct 21
$0.17
10Y Growth
-3.58%
5Y Growth
-6.99%
3Y Growth
-12.37%
1Y Growth
N/A

Earnings

3MarExpected
Q4 2020
Q1 2021
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
0.18
0.37
0.55
Expected EPS
N/A
Actual EPS
N/A

Financials

-2.6%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
4.82BRevenue
-125.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APNHY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Aspen in various therapeutic areas, including anti-infectives and cardiovascular drugs.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that competes across several of the same therapeutic areas as Aspen, including generic medicines through its Sandoz division.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that compete with Aspen's portfolio, including in the areas of women's health and general medicines.
Merck
MRK
Mkt Cap214.76B
Merck is a global healthcare company that competes with Aspen, particularly in the areas of infectious diseases and cardiovascular health.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes with Aspen in the development and marketing of pharmaceuticals and vaccines, including in respiratory diseases and HIV.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes with Aspen in the pharmaceutical sector, particularly in the areas of immunology and oncology, areas Aspen is expanding into.
Sanofi
SNY
Mkt Cap124.45B
Sanofi competes with Aspen, offering a broad portfolio of drugs that overlap with Aspen's, including in the areas of cardiovascular diseases and central nervous system disorders.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a leading generic pharmaceutical company that competes with Aspen's manufacturing and distribution of generic medicines.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca competes with Aspen in several therapeutic areas, including respiratory, cardiovascular, and metabolic diseases, areas where Aspen also operates.

About

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.
Show more...
CEO
Mr. Stephen Bradley Saad BCom, CA(SA)
Employees
8867
Country
ZA
ISIN
US04530Y1064

Listings

0 Comments

Share your thoughts

FAQ

What is Aspen Pharmacare stock price today?
The current price of APNHY is $8.08 USD — it has increased by +5.9% in the past 24 hours. Watch Aspen Pharmacare stock price performance more closely on the chart.
What is Aspen Pharmacare stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aspen Pharmacare stocks are traded under the ticker APNHY.
Is Aspen Pharmacare stock price growing?
APNHY stock has risen by +5.9% compared to the previous week, the month change is a -3.12% fall, over the last year Aspen Pharmacare has showed a -6.29% decrease.
What is Aspen Pharmacare market cap?
Today Aspen Pharmacare has the market capitalization of 3.61B
When is the next Aspen Pharmacare earnings date?
Aspen Pharmacare is going to release the next earnings report on September 02, 2026.
What is Aspen Pharmacare revenue for the last year?
Aspen Pharmacare revenue for the last year amounts to 4.82B USD.
What is Aspen Pharmacare net income for the last year?
APNHY net income for the last year is -125.61M USD.
Does Aspen Pharmacare pay dividends?
Yes, APNHY dividends are paid annual. The last dividend per share was 0.12 USD. As of today, Dividend Yield (FWD)% is 1.49%.
How many employees does Aspen Pharmacare have?
As of April 02, 2026, the company has 8,867 employees.
In which sector is Aspen Pharmacare located?
Aspen Pharmacare operates in the Health Care sector.
When did Aspen Pharmacare complete a stock split?
The last stock split for Aspen Pharmacare was on July 18, 2012 with a ratio of 5:1.
Where is Aspen Pharmacare headquartered?
Aspen Pharmacare is headquartered in Durban, ZA.